遺伝子発現解析市場：オファリング、アプリケーション、エンドユーザー別-2025-2030年世界予測

遺伝子発現解析市場は、2023年に40億米ドルと評価され、2024年には43億米ドルに達すると予測され、CAGR 7.80％で成長し、2030年には67億7,000万米ドルになると予測されています。

遺伝子発現解析は、様々な生物学的状態における遺伝子の活性（発現）を調べることであり、疾患、薬物相互作用、開発プロセスの理解に不可欠です。その必要性は、個別化医療における極めて重要な役割から生じており、疾患マーカーや治療標的の同定を助け、最終的に患者の転帰を改善します。用途は腫瘍学、薬理ゲノム学、農業バイオテクノロジーに及び、研究室、製薬会社、臨床診断で使用されています。市場成長の原動力は、精密医療に対する需要の高まり、シーケンス技術の進歩、慢性疾患の増加です。特に、RNA-seqとハイスループットマイクロアレイ技術の登場は、研究者の遺伝子解析へのアプローチ方法に革命をもたらし、より包括的なデータ収集と解析を可能にしています。

しかし、この市場には、高度なプラットフォームの高コストや、ビッグデータの取り扱いにおけるストレージや解釈の複雑さなど、データ管理の課題といった制約がつきまとう。また、厳しい規制の枠組みも、イノベーションと採用率を鈍らせる要因となっています。しかし、データ分析のためにAIと機械学習を統合し、スピードと精度の両方を向上させる、費用対効果の高い迅速な診断ツールの開発には潜在的な機会が存在します。データ解釈を合理化・簡素化するアプリケーションの開発は、データ生成と臨床応用のギャップを埋めることもできます。これは、個別化治療を推進できる大規模データセットの有用性を高める上で特に重要です。

遺伝子編集技術を発現解析と統合したり、シングルセルRNAシーケンスに注目したりといった革新的な分野は、今後の成長が大いに期待されます。さらに、遺伝子発現の洞察を通じて作物の抵抗性や収量を高めることを目的とした農業バイオテクノロジーにおける新規アプリケーションは、市場の成長チャネルを多様化させる可能性があります。業界の進歩を推進するためには、研究機関と技術開発者の協力が不可欠です。課題はあるもの、強力なパートナーシップと研究開発への投資を通じて、こうした革新的な前線に焦点を当て、技術導入戦略を最適化することで、企業は今後の市場機会を効率的に活用することができます。

市場力学：急速に進化する遺伝子発現解析市場の主要市場インサイトを公開

遺伝子発現解析市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の増加
  • 遺伝子ベースの診断に対する嗜好の高まり
  • 遺伝子編集技術、シークエンシング、バイオインフォマティクスの進歩の高まり
• 市場抑制要因
  • 熟練労働者の不足、機器や消耗品に関連する費用
• 市場機会
  • 精密腫瘍学への注目の高まり
  • オーダーメイド医療へのニーズの高まり
• 市場の課題
  • データの解釈に関する懸念

ポーターのファイブフォース：遺伝子発現解析市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：遺伝子発現解析市場における外部からの影響の把握

外部マクロ環境要因は、遺伝子発現解析市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析遺伝子発現解析市場における競合情勢の把握

遺伝子発現解析市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス遺伝子発現解析市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、遺伝子発現解析市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨遺伝子発現解析市場における成功への道筋を描く

遺伝子発現解析市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延
    • 遺伝子に基づく診断への関心が高まる
    • 遺伝子編集技術、シーケンシング、バイオインフォマティクスの進歩
  • 抑制要因
    • 熟練した労働力の不足と器具や消耗品に関連する費用
  • 機会
    • 精密腫瘍学への注目が高まる
    • カスタマイズ医療のニーズの高まり
  • 課題
    • データの解釈に関する懸念
• 市場セグメンテーション分析
  • 提供内容：特異性と拡張性を備えた高度な機器の採用拡大
  • 応用：薬物ターゲットの特定を効率化する上での遺伝子発現解析の重要性の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 遺伝子発現解析市場：提供別

• 機器
  • マイクロアレイスキャナ
  • 次世代シーケンシング（NGS）プラットフォーム
  • PCR
• 試薬・消耗品
  • アッセイとキット
  • DNAマイクロアレイ
  • 酵素
• サービス

第7章 遺伝子発現解析市場：用途別

• 臨床診断
• 医薬品の発見と開発

第8章 遺伝子発現解析市場：エンドユーザー別

• 学術・調査機関
• 診断検査室
• 製薬・バイオテクノロジー企業

第9章 南北アメリカの遺伝子発現解析市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の遺伝子発現解析市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの遺伝子発現解析市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • サーモフィッシャーサイエンティフィックは、RNA処理を効率化するインビトロジェンTaqMan Cells-to-CT Expressキットを発売しました。
  • Tempusは、スタンドアロンのRNAシークエンシングテストであるTempus xRを発売しました。
  • QIAGEN、強化されたQIAGEN CLC Genomics Workbench Premiumを発売
• 戦略分析と提言

企業一覧

• 10x Genomics
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• BioSpyder, Inc.
• CD Genomics
• Charles River Laboratories International, Inc.
• Danaher Corporation
• DiaSorin S.p.A.
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• Illumina Inc.
• Inotiv, Inc.
• LGC Limited
• Merck KGaA
• Meridian Bioscience, Inc.
• NanoString Technologies Inc.
• New England Biolab
• Oxford Gene Technology IP Limited
• Oxford Nanopore Technologies plc
• Promega Corporation
• QIAGEN N.V.
• Revvity, Inc.
• Standard BioTools
• Takara Bio, Inc.
• Thermo Fisher Scientific Inc
• Zymo Research Corporation

LIST OF FIGURES

• FIGURE 1. GENE EXPRESSION ANALYSIS MARKET RESEARCH PROCESS
• FIGURE 2. GENE EXPRESSION ANALYSIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. GENE EXPRESSION ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. GENE EXPRESSION ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENE EXPRESSION ANALYSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENE EXPRESSION ANALYSIS MARKET DYNAMICS
• TABLE 7. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS) PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY ASSAYS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GENE EXPRESSION ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 43. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 44. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 45. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CANADA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 70. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 71. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 72. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. CHINA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 75. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 76. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 77. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. INDIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 161. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 162. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 163. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ITALY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 181. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 182. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 183. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. POLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 186. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 187. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 188. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. QATAR GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM GENE EXPRESSION ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. GENE EXPRESSION ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. GENE EXPRESSION ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

The Gene Expression Analysis Market was valued at USD 4.00 billion in 2023, expected to reach USD 4.30 billion in 2024, and is projected to grow at a CAGR of 7.80%, to USD 6.77 billion by 2030.

Gene expression analysis involves examining the activity (expression) of genes in various biological conditions, making it integral to understanding diseases, drug interactions, and development processes. Its necessity arises from its pivotal role in personalized medicine, where it aids in identifying disease markers and therapeutic targets, ultimately improving patient outcomes. Applications span across oncology, pharmacogenomics, and agricultural biotechnology, with usage in research laboratories, pharmaceutical companies, and clinical diagnostics. Market growth is driven by increased demand for precision medicine, advancements in sequencing technologies, and rising incidences of chronic diseases. Particularly, the advent of RNA-seq and high-throughput microarray technologies has revolutionized how researchers approach genetic analyses, allowing more comprehensive data collection and analysis.

However, the market is fraught with limitations like high costs of advanced platforms and data management challenges, including storage and interpretation complexities in handling big data. Stringent regulatory frameworks can also slow innovation and adoption rates. Yet, potential opportunities exist in developing cost-effective, rapid diagnostic tools that integrate AI and machine learning for data analysis, improving both speed and accuracy. Developing applications that streamline and simplify data interpretation can also bridge gaps between data generation and clinical application. This is particularly crucial in increasing the utility of large datasets, which can drive personalized therapies.

Innovative areas such as integrating gene editing technologies with expression analysis or focusing on single-cell RNA sequencing hold substantial promise for growth. Furthermore, novel applications in agricultural biotech, aiming to enhance crop resistance and yield through gene expression insights, can diversify market growth channels. Collaboration between research entities and tech developers will be vital for propelling industry advancements. Despite challenges, focusing on these innovative fronts and optimizing technology adoption strategies through strong partnerships and investment in R&D can position businesses to harness upcoming market opportunities efficiently.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Expression Analysis Market

The Gene Expression Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of chronic diseases
  • Increasing preference for gene-based diagnostics
  • Growing advancements in gene editing technology, sequencing, and bioinformatics
• Market Restraints
  • Lack of skilled labor and expenses associated with the instruments and consumables
• Market Opportunities
  • Increasing focus on precision oncology
  • Rising need for customized medicine
• Market Challenges
  • Concerns associated with the interpretation of data

Porter's Five Forces: A Strategic Tool for Navigating the Gene Expression Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Expression Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Expression Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Expression Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Expression Analysis Market

A detailed market share analysis in the Gene Expression Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Expression Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Expression Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Expression Analysis Market

A strategic analysis of the Gene Expression Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Expression Analysis Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSpyder, Inc., CD Genomics, Charles River Laboratories International, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina Inc., Inotiv, Inc., LGC Limited, Merck KGaA, Meridian Bioscience, Inc., NanoString Technologies Inc., New England Biolab, Oxford Gene Technology IP Limited, Oxford Nanopore Technologies plc, Promega Corporation, QIAGEN N.V., Revvity, Inc., Standard BioTools, Takara Bio, Inc., Thermo Fisher Scientific Inc, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Expression Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Instruments, Reagents & Consumables, and Services. The Instruments is further studied across Microarray Scanners, Next-generation Sequencing (NGS) Platforms, and PCR. The Reagents & Consumables is further studied across Assays & Kits, DNA Microarray, and Enzymes.
• Based on Application, market is studied across Clinical Diagnostics and Drug Discovery & Development.
• Based on End-user, market is studied across Academic & Research Institutions, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic diseases
    • 5.1.1.2. Increasing preference for gene-based diagnostics
    • 5.1.1.3. Growing advancements in gene editing technology, sequencing, and bioinformatics
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled labor and expenses associated with the instruments and consumables
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing focus on precision oncology
    • 5.1.3.2. Rising need for customized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with the interpretation of data
• 5.2. Market Segmentation Analysis
  • 5.2.1. Offering: Growing adoption of advanced instruments with specificity and scalability
  • 5.2.2. Application: Rising significance of gene expression analysis in streamlining the identification of drug targets
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gene Expression Analysis Market, by Offering

• 6.1. Introduction
• 6.2. Instruments
  • 6.2.1. Microarray Scanners
  • 6.2.2. Next-generation Sequencing (NGS) Platforms
  • 6.2.3. PCR
• 6.3. Reagents & Consumables
  • 6.3.1. Assays & Kits
  • 6.3.2. DNA Microarray
  • 6.3.3. Enzymes
• 6.4. Services

7. Gene Expression Analysis Market, by Application

• 7.1. Introduction
• 7.2. Clinical Diagnostics
• 7.3. Drug Discovery & Development

8. Gene Expression Analysis Market, by End-user

• 8.1. Introduction
• 8.2. Academic & Research Institutions
• 8.3. Diagnostic Laboratories
• 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Gene Expression Analysis Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Gene Expression Analysis Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Gene Expression Analysis Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Thermo Fisher Scientific Launched the Invitrogen TaqMan Cells-to-CT Express Kit for Streamlined RNA Processing
  • 12.3.2. Tempus launched Tempus xR, a standalone RNA Sequencing Test
  • 12.3.3. QIAGEN Launched Enhanced QIAGEN CLC Genomics Workbench Premium
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics
• 2. Agilent Technologies Inc.
• 3. Bio-Rad Laboratories Inc.
• 4. BioSpyder, Inc.
• 5. CD Genomics
• 6. Charles River Laboratories International, Inc.
• 7. Danaher Corporation
• 8. DiaSorin S.p.A.
• 9. Eurofins Scientific SE
• 10. F. Hoffmann-La Roche Ltd.
• 11. Illumina Inc.
• 12. Inotiv, Inc.
• 13. LGC Limited
• 14. Merck KGaA
• 15. Meridian Bioscience, Inc.
• 16. NanoString Technologies Inc.
• 17. New England Biolab
• 18. Oxford Gene Technology IP Limited
• 19. Oxford Nanopore Technologies plc
• 20. Promega Corporation
• 21. QIAGEN N.V.
• 22. Revvity, Inc.
• 23. Standard BioTools
• 24. Takara Bio, Inc.
• 25. Thermo Fisher Scientific Inc
• 26. Zymo Research Corporation